For research use only. Not for use in humans.

Namilumab (Anti-CSF2 / GM-CSF)

Synonyms: AMG-203

Namilumab (Anti-CSF2 / GM-CSF) is a human immunoglobulin G1 (IgG1) monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. MW: 145.78 KD.

Namilumab (Anti-CSF2 / GM-CSF)

Quality Control

Batch: A285501 Purity: 99% Protein concentration: 4.2mg/ml Endotoxin Level: <1EU/mg
99

Mechanism of Action

Description
Namilumab (Anti-CSF2 / GM-CSF) is a human immunoglobulin G1 (IgG1) monoclonal antibody that binds with high affinity to the GM-CSF ligand, potently neutralizing GM-CSF. MW: 145.78 KD.
References

Product Details

CAS No. 1206681-39-1
Molecular Weight 145.78
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.